Literature DB >> 33707464

Higher PGD2 production by synovial mast cells from rheumatoid arthritis patients compared with osteoarthritis patients via miR-199a-3p/prostaglandin synthetase 2 axis.

Shintaro Mishima1,2, Jun-Ichi Kashiwakura1,3, Shota Toyoshima1,4,5, Tomomi Sasaki-Sakamoto1,4,5, Yutaka Sano1,2, Kazuyoshi Nakanishi2, Kenji Matsumoto6, Yoshimichi Okayama7,8,9.   

Abstract

We previously reported that synovial mast cells (MCs) from patients with rheumatoid arthritis (RA) produced TNF-α in response to immune complexes via FcγRI and FcγRIIA. However, the specific functions of synovial MCs in RA remain unclear. This study aimed to elucidate those functions. Synovial tissues and fluid were obtained from RA and osteoarthritis (OA) patients undergoing joint replacement surgery. Synovium-derived, cultured MCs were generated by culturing dispersed synovial cells with stem cell factor. We performed microarray-based screening of mRNA and microRNA (miRNA), followed by quantitative RT-PCR-based verification. Synovial MCs from RA patients showed significantly higher prostaglandin systhetase (PTGS)1 and PTGS2 expression compared with OA patients' MCs, and they produced significantly more prostaglandin D2 (PGD2) following aggregation of FcγRI. PGD2 induced IL-8 production by human group 2 innate lymphoid cells, suggesting that PGD2-producing MCs induce neutrophil recruitment into the synovium of RA patients. PTGS2 mRNA expression in RA patients' MCs correlated inversely with miRNA-199a-3p expression, which down-regulated PTGS2. RA patients' synovial fluid contained significantly more PGD2 compared with OA patients' fluid. Synovial MCs might regulate inflammation in RA through hyper-production of PGD2 following FcRγ aggregation. Our findings indicate functional heterogeneity of human MCs among diseases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707464      PMCID: PMC7952410          DOI: 10.1038/s41598-021-84963-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  49 in total

1.  A deficiency in the prostaglandin D2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation.

Authors:  Yoshiki Tsubosaka; Tatsuro Nakamura; Hiroyuki Hirai; Masatoshi Hori; Masataka Nakamura; Hiroshi Ozaki; Takahisa Murata
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

2.  The FcRβ- and γ-ITAMs play crucial but distinct roles in the full activation of mast cells induced by IgEκ and Protein L.

Authors:  Satoshi Nunomura; Yuko Kawakami; Toshiaki Kawakami; Chisei Ra
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

3.  Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis.

Authors:  D Egg
Journal:  Z Rheumatol       Date:  1984 Mar-Apr       Impact factor: 1.372

4.  MicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes.

Authors:  Nahid Akhtar; Tariq M Haqqi
Journal:  Ann Rheum Dis       Date:  2012-01-31       Impact factor: 19.103

5.  Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis.

Authors:  Nuria Maicas; Lidia Ibáñez; María José Alcaraz; Amalia Úbeda; María Luisa Ferrándiz
Journal:  Arthritis Rheum       Date:  2012-01

6.  Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells.

Authors:  Ben Roediger; Ryan Kyle; Kwok Ho Yip; Nital Sumaria; Thomas V Guy; Brian S Kim; Andrew J Mitchell; Szun S Tay; Rohit Jain; Elizabeth Forbes-Blom; Xi Chen; Philip L Tong; Holly A Bolton; David Artis; William E Paul; Barbara Fazekas de St Groth; Michele A Grimbaldeston; Graham Le Gros; Wolfgang Weninger
Journal:  Nat Immunol       Date:  2013-04-21       Impact factor: 25.606

7.  Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis.

Authors:  Takashi Kuwano; Shintaro Nakao; Hidetaka Yamamoto; Masazumi Tsuneyoshi; Tomoya Yamamoto; Michihiko Kuwano; Mayumi Ono
Journal:  FASEB J       Date:  2004-02       Impact factor: 5.191

Review 8.  Persisting eicosanoid pathways in rheumatic diseases.

Authors:  Marina Korotkova; Per-Johan Jakobsson
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

Review 9.  Discovery of anti-inflammatory role of prostaglandin D2.

Authors:  Takahisa Murata; Toko Maehara
Journal:  J Vet Med Sci       Date:  2016-08-05       Impact factor: 1.267

10.  circFADS2 protects LPS-treated chondrocytes from apoptosis acting as an interceptor of miR-498/mTOR cross-talking.

Authors:  Guoqing Li; Wei Tan; Yuxuan Fang; Xia Wu; Wei Zhou; Chunwang Zhang; Yu Zhang; Yanqing Liu; Guangzheng Jiu; Dan Liu
Journal:  Aging (Albany NY)       Date:  2019-05-29       Impact factor: 5.682

View more
  3 in total

1.  Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research.

Authors:  Celia Cartagena García; Nathalie Balandraud; Jean Roudier; Pierre Lafforgue; Nathalie Lambert; Jean-Marc Busnel
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

2.  Biosynthesis of gold nanoparticles for the treatment of osteoarthritis alone or in combination with Diacerein® in a rat model.

Authors:  Manal A Abdel-Aziz; Helmy M S Ahmed; Aziza A El-Nekeety; Hafiza A Sharaf; Sekena H Abdel-Aziem; Mosaad A Abdel-Wahhab
Journal:  Inflammopharmacology       Date:  2021-06-11       Impact factor: 4.473

Review 3.  Intra-Articular Drug Delivery for Osteoarthritis Treatment.

Authors:  Yifeng Cao; Yifeng Ma; Yi Tao; Weifeng Lin; Ping Wang
Journal:  Pharmaceutics       Date:  2021-12-15       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.